Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Generics [UK] Limited, T/A Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL
Pindolol Tablets 5mg.
| Pharmaceutical Form |
|---|
|
Tablet. White, flat bevelled edged tablet, marked “PL” breakline “5” on one side of the tablet and “G” on the reverse. |
Each tablet contains pindolol 5 mg.
For the full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pindolol |
Pindolol is a potent beta-adrenoceptor antagonist (beta-blocker) with uses similar to those of propranolol. It is classified as non cardioselective. It blocks both B1- and B2-adrenoceptors for more than 24 hours after administration. It has negligible membrane-stabilising activity. Pindolol exhibits low cardiodepressant activity at therapeutic dose. |
| List of Excipients |
|---|
|
Cellulose, microcrystalline |
Polypropylene containers with polyethylene caps (with optional use of polyethylene ullage filler) and PVC/aluminium foil blister packs containing 5, 7, 10, 14, 15, 20, 21, 25, 28, 30, 56, 60, 84, 90, 100, 112, 120, 168, 180, 250, 500 and 1000 tablets.
Not all pack sizes may be marketed.
Generics [UK] Limited, T/A Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL
PL 04569/0118
Date of first authorisation: 7th October 1986
Date of latest renewal: 23rd February 2004
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
